The second quarter was a record-breaking period with China-focused biopharma start-ups and others raising hundreds of millions of dollars in venture capital. Both the amount of money raised and the nu
Marrying legendary small molecule therapeutic development expertise with a deep understanding of novel immune therapies is one way to make a splash in the crowded immuno-oncology space. Taking four pr
Big money continues to flow into biopharmaceutical startups, especially those helmed by former big pharma and large biotech executives – the latest being Vir Biotechnology Inc. , which recruited ex-
IN VITRO DIAGNOSTICS Alliances AEterna Zentaris Inc. Armune BioScience Inc. Armune BioScience Inc. granted AEterna Zentaris Inc. rights to sell its Apifiny prostate cancer diagnostic to desi